Mr Martyn, who joins from a major Irish law firm, is admitted to practise as a solicitor in Ireland, England and Wales and Queensland, Australia.

Hiis career highlights include leading cross-border patent litigation for blue-chip pharmaceutical products and managing multi-jurisdictional IP litigation across Europe, with his expertise extending to life cycle management of medicinal products, regulatory advice, and advising on European data and marketing exclusivity.

Adam Griffiths, head of Taylor Wessing’s Dublin office, said: “Eoin’s appointment represents another significant milestone in the journey of Taylor Wessing Ireland.

“We are thrilled to welcome Eoin, who joins at a very exciting time for our distinguished international patents and innovation practice.

“Eoin brings a wealth of experience from the pharmaceutical and biotechnology sectors, and his impressive track record will be a great asset to Taylor Wessing in Ireland and across our global platform.”

Shane Gleghorn, co-chair of Taylor Wessing’s global board, added: “We are focused on recruiting exceptional talent, and Eoin’s arrival significantly bolsters our patent and IP offering in Ireland.

“TW is known as the firm of choice for cross-border patent litigation where the client requires the firm to deploy multi-jurisdictional teams of the best patent litigators.

“Eoin’s appointment to our Irish team will allow us to consolidate and grow that position, and provide patent/IP services to our clients in the Irish market.”

Mr Martyn said: “I am delighted to join Taylor Wessing. This is a fantastic opportunity in an international firm with a global outreach. There has been a significant increase in pharmaceutical patent litigation in Ireland in recent years and this continues to grow at pace.

“Taylor Wessing is renowned for its expertise in this area and, with its specialist Unified Patent Court group, is ideally positioned to provide market-leading support and assistance to a wide range of clients in Ireland and overseas. I am very much looking forward to joining the team and building on this success.”